Image

ChOlecystectomy aFter successFul Endoscopic Common Bile Duct Stone Extraction in Elderly

ChOlecystectomy aFter successFul Endoscopic Common Bile Duct Stone Extraction in Elderly

Recruiting
75 years and older
All
Phase N/A

Powered by AI

Overview

The goal of this study is to compare safety and efficacy of laparoscopic cholecystectomy versus wait-and-see policy after endoscopic removal of common bile duct stones in elderly. The primary endpoint is a composite outcome: Death or major postoperative complications or recurrent biliary disease within 1 year after randomization.

Description

Elderly patients with common bile duct stones are asked to participate this randomized trial after successful endoscopic removal of common bile duct stones. The hypothesis of the study is that wait-and-see policy is non-inferior to laparoscopic cholecystectomy. Four hundred patients are randomized 1:1 to either laparoscopic cholecystectomy group or wait-and see group. Cholecystectomy is done on the same admission or within two weeks after randomization. One interim analysis is planned for the trial after 100 randomized patients to assess safety. The trial is terminated if there is a statistically significant difference in primary outcome with p<0.001 (chi-square test) between the study arms.

Eligibility

Inclusion Criteria:

  • Common bile duct stones cleared after Endoscopic Retrograde Cholangio Pancreatography (ERCP)
  • Age >= 80 years or age 75-79 years with a Charlson Comorbidity index >=2
  • gallbladder in situ

Exclusion Criteria:

  • Acute Cholecystitis
  • Biliary Pancreatitis
  • Severe or moderately severe post-ERCP pancreatitis
  • Chronic pancreatitis
  • Bile duct pathology
  • Widespread malignancy
  • Unable to give consent

Study details
    Cholecystectomy
    Laparoscopic
    Choledocholithiasis
    Cholelithiasis

NCT07001423

Helsinki University Central Hospital

15 October 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.